Darby Schmidt

1.9k total citations · 1 hit paper
18 papers, 787 citations indexed

About

Darby Schmidt is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Darby Schmidt has authored 18 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Darby Schmidt's work include Synthetic Organic Chemistry Methods (3 papers), Cholesterol and Lipid Metabolism (3 papers) and Acute Myeloid Leukemia Research (2 papers). Darby Schmidt is often cited by papers focused on Synthetic Organic Chemistry Methods (3 papers), Cholesterol and Lipid Metabolism (3 papers) and Acute Myeloid Leukemia Research (2 papers). Darby Schmidt collaborates with scholars based in United States, United Kingdom and Algeria. Darby Schmidt's co-authors include James L. Leighton, Stuart L. Schreiber, Lorenzo Galluzzi, Guido Kroemer, Emma Guilbaud, Francesco M. Marincola, Peter K. Park, Steven J. O'Malley, Ohyun Kwon and Mercedes Lobera and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Blood.

In The Last Decade

Darby Schmidt

18 papers receiving 779 citations

Hit Papers

Targeting immunogenic cell stress and death for cancer th... 2024 2026 2025 2024 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Darby Schmidt United States 11 290 269 189 142 80 18 787
Goreti Ribeiro Morais United Kingdom 15 285 1.0× 248 0.9× 52 0.3× 138 1.0× 39 0.5× 51 613
Jidong Zhu China 14 198 0.7× 752 2.8× 95 0.5× 146 1.0× 23 0.3× 34 1.1k
Dandan Yuan China 17 107 0.4× 389 1.4× 58 0.3× 243 1.7× 75 0.9× 50 792
Kaushik Banerjee India 16 132 0.5× 174 0.6× 69 0.4× 259 1.8× 58 0.7× 30 574
Shuaixiang Zhou China 14 81 0.3× 333 1.2× 176 0.9× 217 1.5× 24 0.3× 24 725
Xiaolu Zhang China 14 219 0.8× 303 1.1× 81 0.4× 135 1.0× 18 0.2× 43 774
Marta Soler Spain 15 136 0.5× 262 1.0× 62 0.3× 95 0.7× 19 0.2× 24 615
Naniye Mallı Cetinbas Canada 8 122 0.4× 573 2.1× 233 1.2× 226 1.6× 18 0.2× 12 822
Izabela Młynarczuk-Biały Poland 14 155 0.5× 351 1.3× 74 0.4× 220 1.5× 23 0.3× 42 732
Andrew McGown United Kingdom 11 107 0.4× 325 1.2× 56 0.3× 228 1.6× 32 0.4× 28 661

Countries citing papers authored by Darby Schmidt

Since Specialization
Citations

This map shows the geographic impact of Darby Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darby Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darby Schmidt more than expected).

Fields of papers citing papers by Darby Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darby Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darby Schmidt. The network helps show where Darby Schmidt may publish in the future.

Co-authorship network of co-authors of Darby Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Darby Schmidt. A scholar is included among the top collaborators of Darby Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darby Schmidt. Darby Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Galluzzi, Lorenzo, Emma Guilbaud, Darby Schmidt, Guido Kroemer, & Francesco M. Marincola. (2024). Targeting immunogenic cell stress and death for cancer therapy. Nature Reviews Drug Discovery. 23(6). 445–460. 214 indexed citations breakdown →
2.
Marineau, Jason, Kristin B. Hamman, Shanhu Hu, et al.. (2021). Discovery of SY-5609: A Selective, Noncovalent Inhibitor of CDK7. Journal of Medicinal Chemistry. 65(2). 1458–1480. 53 indexed citations
3.
Schmidt, Darby & Christopher Thompson. (2020). Case studies in rare disease small molecule discovery and development. Bioorganic & Medicinal Chemistry Letters. 30(21). 127462–127462. 1 indexed citations
4.
Hu, Shanhu, Nan Rosemary Ke, Yixuan Ren, et al.. (2016). Abstract 4820: Selective CDK7 inhibitors suppress super enhancer-genes, induce massive apoptosis in acute myeloid leukemia and demonstrate durable in vivo efficacy. Cancer Research. 76(14_Supplement). 4820–4820. 1 indexed citations
5.
Skepner, Jill, Radha Ramesh, Xiaoyan A. Qu, et al.. (2015). In vivo regulation of gene expression and T helper type 17 differentiation by RORγt inverse agonists. Immunology. 145(3). 347–356. 14 indexed citations
6.
Ren, Yixuan, Victoria Brown, Shanhu Hu, et al.. (2015). Targeting Transcriptional Dependency in Acute Myeloid Leukemia (AML) with a Covalent Inhibitor of Transcriptional Kinase CDK7. Blood. 126(23). 1354–1354. 1 indexed citations
7.
Skepner, Jill, Radha Ramesh, Darby Schmidt, et al.. (2014). Pharmacologic Inhibition of RORγt Regulates Th17 Signature Gene Expression and Suppresses Cutaneous Inflammation In Vivo. The Journal of Immunology. 192(6). 2564–2575. 115 indexed citations
8.
Schmidt, Darby, Subharekha Raghavan, Hong C. Shen, et al.. (2010). Anthranilic acid replacements in a niacin receptor agonist. Bioorganic & Medicinal Chemistry Letters. 20(11). 3426–3430. 17 indexed citations
9.
Imbriglio, Jason E., Rui Liang, Subharekha Raghavan, et al.. (2010). GPR109a agonists. Part 2: Pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109a. Bioorganic & Medicinal Chemistry Letters. 20(15). 4472–4474. 10 indexed citations
10.
Schmidt, Darby, Subharekha Raghavan, Ester Carballo‐Jane, et al.. (2009). Pyrazole acids as niacin receptor agonists for the treatment of dyslipidemia. Bioorganic & Medicinal Chemistry Letters. 19(16). 4768–4772. 10 indexed citations
11.
Imbriglio, Jason E., Rui Liang, Subharekha Raghavan, et al.. (2009). GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole–tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a. Bioorganic & Medicinal Chemistry Letters. 19(8). 2121–2124. 13 indexed citations
13.
Park, Peter K., Steven J. O'Malley, Darby Schmidt, & James L. Leighton. (2006). Total Synthesis of Dolabelide D. Journal of the American Chemical Society. 128(9). 2796–2797. 52 indexed citations
14.
Schmidt, Darby, Ohyun Kwon, & Stuart L. Schreiber. (2004). Macrolactones in Diversity-Oriented Synthesis:  Preparation of a Pilot Library and Exploration of Factors Controlling Macrocyclization. Journal of Combinatorial Chemistry. 6(2). 286–292. 31 indexed citations
15.
Schmidt, Darby, Peter K. Park, & James L. Leighton. (2003). Approach to the Synthesis of Dolabelides A and B:  Fragment Synthesis by Tandem Silylformylation−Crotylsilylation. Organic Letters. 5(19). 3535–3537. 29 indexed citations
16.
Schmidt, Darby, et al.. (2003). Catalytic Asymmetric Silane Alcoholysis:  Practical Access to Chiral Silanes. Journal of the American Chemical Society. 125(5). 1190–1191. 146 indexed citations
17.
Schmidt, Darby & Stuart L. Schreiber. (1999). Molecular Association between ATR and Two Components of the Nucleosome Remodeling and Deacetylating Complex, HDAC2 and CHD4. Biochemistry. 38(44). 14711–14717. 71 indexed citations
18.
Pal, Santona, et al.. (1997). Skn-1: Evidence for a bipartite recognition helix in DNA binding. Proceedings of the National Academy of Sciences. 94(11). 5556–5561. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026